SSA
ABBV icon

Sierra Summit Advisors’s AbbVie ABBV Stock Holding History

Sierra Summit Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.39M Sell
17,459
-296
-2% -$63.7K 0.49% 39
2026
Q1 		$3.86M Buy
17,755
+1,835
+12% +$407K 0.56% 41
2025
Q4 		$3.64M Buy
15,920
+325
+2% +$74K 0.56% 36
2025
Q3 		$3.61M Buy
15,595
+109
+0.7% +$22.2K 0.55% 38
2025
Q2 		$2.87M Buy
15,486
+188
+1% +$34.9K 0.51% 37
2025
Q1 		$3.21M Sell
15,298
-389
-2% -$75.6K 0.69% 36
2024
Q4 		$2.79M Buy
15,687
+2,151
+16% +$395K 0.56% 36
2024
Q3 		$2.67M Buy
13,536
+1,439
+12% +$269K 0.61% 35
2024
Q2 		$2.07M Buy
12,097
+1,155
+11% +$191K 0.51% 40
2024
Q1 		$1.99M Buy
10,942
+29
+0.3% +$5K 0.54% 36
2023
Q4 		$1.69M Buy
+10,913
New +$1.59M 0.49% 42

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sierra Summit Advisors's ABBV Position: Q2 2026 in Review

Sierra Summit Advisors reduced its AbbVie (ABBV) stake by 1.7% in Q2 2026, selling an estimated $63.7K and leaving 17,459 shares worth $4.39M. The position accounts for 0.49% of the portfolio, ranked #39.

Sierra Summit Advisors first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sierra Summit Advisors held 17,459 shares of AbbVie worth $4.39M as of Q2 2026.
  • Sierra Summit Advisors sold 296 AbbVie shares in Q2 2026, an estimated $63.7K.
  • AbbVie made up 0.49% of Sierra Summit Advisors's portfolio in Q2 2026, its #39 holding.
  • Sierra Summit Advisors first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sierra Summit Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.